Dr. Poolakkil and team present a study on varying clinical presentations and patterns of recurrence of colorectal cancer. What is the incidence of second primary colorectal cancer and what are the salvage rates? Read here to find out: bit.ly/4aAZrVs #CRST

Indian patients with NSCLC have 29% EGFR positivity, 8.1% ALK positivity, and 3.5% ROS1 positivity, when tested with RT-PCR, IHC, and FISH. Read the molecular profile by Dr Munde and team here: bit.ly/3TVVjYS #CRST #ALK #ROS1 #EGFR #CancerResearch #MedTwitter

Dr Singh and team assess the 8-year long-term superiority of gefitinib over chemotherapy in terms of overall and progression-free survival (PFS), objective response rate (ORR), and safety. Read here: bit.ly/4azKlis #CRST #oncology #MedTwitter #cancer #CancerResearch

Dr. Krishnatry and team study the translation and validation of the Hindi, Marathi, and Bangla versions of the European Organization for Research and Treatment of Cancer Quality-of-Life Questionnaire: Anal Cancer (QLQ-ANL27) module. Read here: bit.ly/3TWepzw

Dr. Malik and team present a clinico-epidemiologic study of head-and-neck cancer patients from Haryana, India. The male-to-female ratio was 8.6:1 with a high incidence of oropharyngeal cancer. Read on: bit.ly
#CRST #cancer #oncologia #MedTwitter #CancerResearch

Our new issue is live! Looking forward to your comments and criticism. Sincere thanks to all authors, reviewers, editors and publishers for your contribution.
Read here: bit.ly/3Kf29px
Vanita Noronha, MBBS MD DM Tata Memorial Hospital #CRST #oncology #CancerResearch #MedTwitter

Head-and-neck cancers account for 30-40% of all cancer cases in India. Dr. Prabhash et al. present an update to Indian clinical guidelines for the management of HNSCC. Read here: bit.ly/3UkTTZZ
#headandneckcancer #CRST #CancerTreatment #Cancers #MedTwitter #HNSCC

Dr. Jha and team identify a rare EGFR exon 18 mutation in lung adenocarcinoma using targeted next-generation sequencing. Read the molecular tumor board article here: bit.ly/3NQMIV9 #CRST #moleculartumorboard #genetics #EGFR #lungcancer #cancer #medtwitter

Is pain under-treated in older patients with cancer? Dr. Sehgal and team study the prevalence of untreated pain, pattern of analgesic use in older Indian patients. Read here: bit.ly/3HbCfjB
#CRST #geriatric #oncology #analgesics #CancerResearch #MedTwitter #cancer

What is the prevalence of preoperative anxiety and depression in patients undergoing major oncosurgeries? Dr. Opneja and team present a study from Kerala, India. Read here: bit.ly/47nNQXs #CancerResearch #anxiety #depression #cancer #surgery #oncology #MedTwitter #CRST

What is the prevalence of comorbidities in Indian patients with cancer? Sebastian at al. take a deep dive in their study from Malabar Cancer Center, Kerala, India. Read here: bit.ly/3RMiYtI
#CRST #CancerResearch #MedTwitter #oncologia #cancer #cancer awareness

Parween et al. present a pan-cancer analysis of homologous recombination DNA repair pathway genes in the Indian population. Read here: bit.ly/3GXbtvh
#CancerResearch #CRST #Oncology #DNA   #MedTwitter

In their study from Turkey, Dr. Kaplan and team assess the relationship between self-compassion, post-traumatic growth, and body image in patients with breast cancer. Read here: bit.ly/41EsBQ3
#CRST #oncology #Cancer Research #Cancer #MedTwitter #Turkey #breastcancer

We express gratitude to our reviewers for their time and commitment to the peer review process of the CRST journal in the year 2023. Thank you Dr. Sharada Mailankody. Sharada Mailankody

We express gratitude to our reviewers for their time and commitment to the peer review process of the CRST journal in the year 2023. Thank you Dr. Ankita Nachankar. ANKITA NACHANKAR

We express gratitude to our reviewers for their time and commitment to the peer review process of the CRST journal in the year 2023. Thank you Dr. Prabhat Bhargava. Prabhat Bhargava, DM (Medical Oncology)

We express gratitude to our reviewers for their time and commitment to the peer review process of the CRST journal in the year 2023. Thank you Dr. Saquib Banday. Saquib Zaffar Banday

We express gratitude to our reviewers for their time and commitment to the peer review process of the CRST journal in the year 2023. Thank you Dr. Dilip Vallathol. Dilip Harindran Vallathol

We express gratitude to our reviewers for their time and commitment to the peer review process of the CRST journal in the year 2023. Thank you Dr. Kunal Jobanputra. Dr Kunal Jobanputra MD, DM